Source of Grey market
Page source·read-only·revision 30
Editing is disabled on this mirror. This is the page source as of revision 30, saved by FreightFenna on 14 July 2026. It is shown so that the markup behind the rendered article can be read and reused under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).
4,279 bytes · 56 lines · 3 top-level sections · 4 defined citations. The markup grammar is documented at Project:Manual of style.
{{Infobox concept
| name = Grey market
| subtitle = Supply chain
| Definition = Trade outside authorised channels in genuine goods
| Distinct from = [[Counterfeit peptide|Counterfeit]] trade in non-genuine goods
| Key issue = Provenance and handling history, not identity
}}
The '''grey market''' is trade in genuine goods outside the channels a manufacturer has authorised. It is distinguished from counterfeit trade by the goods being what they claim to be; what is irregular is the route, not the article. See [[Counterfeit peptide]].{{r|reports}}
For research chemicals the term is used loosely, since much of the market operates without authorised channels in the first place. It is most meaningful where a licensed product exists and material is traded outside its distribution system, or where material intended for one use is diverted to another.{{r|ich_q7}}
The substantive issue is provenance and handling. A genuine article that has passed through an unrecorded chain has an unknown storage history, and no analysis performed afterwards can distinguish manufacture from handling as the cause of what it finds.{{r|usp1503}}
== How goods leave authorised channels ==
Diversion occurs at several points: material sold for one purpose and resold for another, quantities in excess of a customer's use resold onward, or stock from one territory sold into another where prices differ.{{r|ich_q7}}
Each of these leaves the goods genuine and the records incomplete. A parallel-imported medicine is the most familiar example and is lawful in some jurisdictions; unrecorded onward sale of research reagents is a less regulated analogue of the same structure.
The identifying feature is a break in the chain rather than a defect in the article. Where a chain is unbroken and documented, the goods are traceable regardless of how many hands they passed through. See [[Lot traceability]].{{r|iso9001}}
== What the term does not mean ==
Three conflations are common and none is sound.
* That grey-market goods are counterfeit. Counterfeit means the goods are not what they claim to be; grey market means they are, by an unauthorised route.
* That grey-market goods are necessarily degraded. Handling history is unknown, which is not the same as bad.
* That any purchase outside a manufacturer's own storefront is grey market. Authorised distributors are authorised channels.
The useful question in each case is documentary: what is recorded about where this material has been, and can it be produced? That is the same question asked at [[Lot traceability]] and [[Chain of custody]], and it does not require the term "grey market" at all.{{r|reports}}
== Relevance to this wiki ==
Most of what this wiki covers is research-chemical supply, in which the concept of an authorised channel is often not defined. The term appears in community discussion, and the article exists to define it rather than because the category is analytically central.{{r|reports}}
Where it does bite is in [[Repackaging|repackaging]] and onward resale, where the practical consequence is a broken record chain, and in [[Customs seizure|importation]], where legal status depends on the article's regulatory category rather than on the trade route.
This wiki sells nothing, is independent of every organisation named in it, and does not advise on the legality of any transaction. Research-use compounds are not approved for human administration.{{r|usp1503}}
== References ==
{{reflist}}
<ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref>
<ref name="ich_q7">International Council for Harmonisation, ''Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients'' (2000).</ref>
<ref name="iso9001">ISO 9001:2015, ''Quality management systems — Requirements''.</ref>
<ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref>
== See also ==
* [[Counterfeit peptide]]
* [[Repackaging]]
* [[Lot traceability]]
* [[Customs seizure]]
* [[Personal importation policy]]
{{DEFAULTSORT:Grey market}}
[[Category:Supply chain integrity]]
[[Category:Regulation and law]]
[[Category:Manufacturing and supply]]
Templates in this source are rendered by the site generator: {{r|id}} becomes a numbered citation, {{figure|key|caption}} a framed diagram, {{main|Title}} a cross-reference line.